Rtw Investments as of Dec. 31, 2019
Portfolio Holdings for Rtw Investments
Rtw Investments holds 60 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rocket Pharmaceuticals (RCKT) | 14.6 | $383M | 17M | 22.76 | |
| Alnylam Pharmaceuticals (ALNY) | 7.2 | $189M | 1.6M | 115.17 | |
| Ptc Therapeutics I (PTCT) | 7.0 | $184M | 3.8M | 48.03 | |
| Dicerna Pharmaceuticals | 4.9 | $129M | 5.9M | 22.03 | |
| Axsome Therapeutics (AXSM) | 4.0 | $106M | 1.0M | 103.36 | |
| Bristol Myers Squibb (BMY) | 4.0 | $106M | 1.6M | 64.19 | |
| Stoke Therapeutics (STOK) | 3.8 | $100M | 3.5M | 28.32 | |
| Homology Medicines | 3.4 | $90M | 4.3M | 20.70 | |
| Mirati Therapeutics | 3.2 | $83M | 645k | 128.86 | |
| Sarepta Therapeutics (SRPT) | 3.0 | $78M | 606k | 129.04 | |
| Adverum Biotechnologies | 2.8 | $74M | 6.4M | 11.52 | |
| Immunovant (IMVT) | 2.5 | $66M | 4.4M | 14.92 | |
| Zimmer Holdings (ZBH) | 2.5 | $66M | 437k | 149.68 | |
| Milestone Pharmaceuticals (MIST) | 2.4 | $63M | 4.0M | 16.01 | |
| Masimo Corporation (MASI) | 2.3 | $60M | 382k | 158.06 | |
| Establishment Labs Holdings Ord (ESTA) | 2.1 | $56M | 2.0M | 27.66 | |
| Myokardia | 2.1 | $56M | 761k | 72.89 | |
| Vericel (VCEL) | 2.0 | $52M | 3.0M | 17.40 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 1.8 | $47M | 4.8M | 9.91 | |
| Achillion Pharmaceuticals | 1.7 | $44M | 7.3M | 6.03 | |
| Axonics Modulation Technolog (AXNX) | 1.7 | $44M | 1.6M | 27.71 | |
| Bellus Health | 1.4 | $37M | 4.8M | 7.55 | |
| Agenus | 1.4 | $36M | 8.9M | 4.07 | |
| Apyx Medical Corporation (APYX) | 1.1 | $29M | 3.4M | 8.46 | |
| Dermtech Ord ord (DMTKQ) | 1.1 | $28M | 2.4M | 11.90 | |
| Arvinas Ord (ARVN) | 1.1 | $28M | 670k | 41.09 | |
| Translate Bio | 1.0 | $27M | 3.3M | 8.14 | |
| Relmada Therapeutics (RLMD) | 1.0 | $26M | 665k | 39.00 | |
| Flamel Technologies Sa | 1.0 | $26M | 3.4M | 7.55 | |
| Frequency Therapeutics | 0.8 | $22M | 1.3M | 16.70 | |
| Castle Biosciences (CSTL) | 0.8 | $22M | 631k | 34.37 | |
| Exagen (XGN) | 0.7 | $18M | 719k | 25.40 | |
| Protagonist Therapeutics (PTGX) | 0.7 | $17M | 2.5M | 7.05 | |
| Johnson & Johnson (JNJ) | 0.7 | $17M | 117k | 145.87 | |
| Nanostring Technologies (NSTGQ) | 0.6 | $16M | 579k | 27.82 | |
| Arbutus Biopharma (ABUS) | 0.6 | $16M | 5.7M | 2.78 | |
| Tela Bio (TELA) | 0.6 | $15M | 1.1M | 12.95 | |
| Natera (NTRA) | 0.5 | $14M | 403k | 33.69 | |
| Wave Life Sciences (WVE) | 0.5 | $14M | 1.7M | 8.01 | |
| Agilent Technologies Inc C ommon (A) | 0.5 | $13M | 150k | 85.31 | |
| Regenxbio Inc equity us cm (RGNX) | 0.5 | $13M | 306k | 40.97 | |
| Insulet Corporation (PODD) | 0.4 | $12M | 68k | 171.21 | |
| Odonate Therapeutics Ord | 0.4 | $12M | 357k | 32.45 | |
| Uniqure Nv (QURE) | 0.4 | $11M | 152k | 71.66 | |
| Clearside Biomedical (CLSD) | 0.4 | $11M | 3.8M | 2.90 | |
| STAAR Surgical Company (STAA) | 0.4 | $11M | 302k | 35.17 | |
| Inmode Ltd. Inmd (INMD) | 0.4 | $9.8M | 250k | 39.20 | |
| Brainsway Ltd- (BWAY) | 0.4 | $9.3M | 958k | 9.75 | |
| Transmedics Group (TMDX) | 0.4 | $9.6M | 503k | 19.01 | |
| La Jolla Pharmaceuticl Com Par | 0.3 | $9.0M | 2.3M | 3.93 | |
| Cytomx Therapeutics (CTMX) | 0.3 | $8.6M | 1.0M | 8.31 | |
| Chardan Healthcare Acqu- Ord | 0.2 | $5.8M | 600k | 9.68 | |
| Argenx Se (ARGX) | 0.2 | $5.1M | 32k | 160.53 | |
| Vivus Inc conv | 0.1 | $2.9M | 4.0M | 0.73 | |
| Personalis Ord (PSNL) | 0.1 | $2.8M | 255k | 10.90 | |
| Motus Gi Hldgs Incorporated | 0.1 | $1.8M | 776k | 2.29 | |
| Fulgent Genetics (FLGT) | 0.0 | $968k | 75k | 12.91 | |
| Viewray (VRAYQ) | 0.0 | $633k | 150k | 4.22 | |
| 10x Genomics Inc Cl A (TXG) | 0.0 | $381k | 5.0k | 76.20 | |
| Chardan Healthcare Acq warrants (PHGEW) | 0.0 | $288k | 600k | 0.48 |
